Found: 6
Select item for more details and to access through your institution.
Integrated multiomic approach for identification of novel immunotherapeutic targets in AML.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00390-4
- By:
- Publication type:
- Article
Integrated multiomic approach for identification of novel immunotherapeutic targets in AML.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00390-4
- By:
- Publication type:
- Article
Correction to: CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2499, doi. 10.1007/s00262-023-03439-x
- By:
- Publication type:
- Article
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1705, doi. 10.1007/s00262-021-03109-w
- By:
- Publication type:
- Article
Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.602802
- By:
- Publication type:
- Article